ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACRX AcelRX Pharmaceuticals Inc

0.86
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AcelRX Pharmaceuticals Inc ACRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.86 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.86 0.86
more quote information »

Recent News

Date Time Source Heading
20/4/202406:37EDGAR2Form 8-K - Current report
22/3/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/3/202407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202401:17EDGAR2Form 8-K - Current report
10/1/202401:05PRNUSAcelRx Announces Rebranding With Name Change to Talphera,..
15/12/202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202308:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202308:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202300:30PRNUSAcelRx Pharmaceuticals Announces Publication of Study..
01/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202308:38EDGAR2Form S-3 - Registration statement under Securities Act of..
23/11/202308:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:14EDGAR2Form 8-K - Current report
09/11/202308:05PRNUSAcelRx Reports Third Quarter 2023 Financial Results and..
08/11/202308:05PRNUSAcelRx to Host KOL Panel Discussion on Current Anticoagulant..
27/10/202307:30PRNUSAcelRx to Host Third Quarter 2023 Financial Results Call and..
21/10/202307:30EDGAR2Form 8-K - Current report
11/10/202307:17EDGAR2Form 8-K - Current report
06/10/202307:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202307:30EDGAR2Form 8-K - Current report
03/10/202323:30PRNUSAcelRx Receives IDE Approval for Niyad and Advances to a..
23/9/202307:18EDGAR2Form 8-K - Current report
12/9/202309:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:30PRNUSAcelRx Pharmaceuticals to Participate in the H.C. Wainwright..
28/8/202320:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/8/202320:34EDGAR2Form DEF 14A - Other definitive proxy statements
26/8/202306:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202302:45EDGAR2Form 144 - Report of proposed sale of securities
25/8/202306:23EDGAR2Form 144 - Report of proposed sale of securities
11/8/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:10EDGAR2Form 8-K - Current report
11/8/202306:05PRNUSAcelRx Reports Second Quarter 2023 Financial Results and..
10/8/202307:29EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
02/8/202320:06EDGAR2Form S-3 - Registration statement under Securities Act of..
28/7/202306:05PRNUSAcelRx to Host Second Quarter 2023 Financial Results Call..
21/7/202322:15EDGAR2Form 8-K - Current report
21/7/202322:00PRNUSAcelRx Pharmaceuticals Announces Closing of Previously..
18/7/202322:00PRNUSAcelRx Pharmaceuticals Announces $10 Million Private..
11/5/202306:05PRNUSAcelRx Pharmaceuticals Reports First Quarter 2023 Financial..
28/4/202306:05PRNUSAcelRx to Host First Quarter 2023 Financial Results Call and..

Your Recent History

Delayed Upgrade Clock